Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
70,868.12
(
-3.03%
)
News Focus
News Focus
Post# of 447270
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

CaptBeer

Send PM Follow Ignore
Followers 62
Posts 4653
Boards Moderated 0
Alias Born 04/23/2013

CaptBeer

Re: dmlcento post# 268354

Wednesday, 04/22/2020 2:28:45 PM

Wednesday, April 22, 2020 2:28:45 PM

Post# of 447270
They do have an encapsulation patent: #8,298,554. It seems to be a "Catch-22". The capsule is patented and is made up from certain chemical compounds. It could consist of a few percentage points of inactive ingredients.

The Catch-22:

The generics capsule would infringe if its makeup is identical.
On the other hand, if its makeup was different then it the product would not meet the definition of "Generic"
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News